COM:ACURAPHARM
Acura Pharmaceuticals, Inc.
- Stock
Market Cap
303.61K
Beta: -
Volume Today
3
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 235K - | 277.50K 18.09% | 290K 4.50% | 292.50K 0.86% | 154.50K 47.18% | ||||||
average payables | 634K - | 245.50K 61.28% | 570.50K 132.38% | 500.50K 12.27% | 40K 92.01% | 304K 660% | 421K 38.49% | 134K 68.17% | 111.50K 16.79% | 96K 13.90% | |
average receivables | 178.50K - | 228K 27.73% | 131K 42.54% | 136K 3.82% | 111.50K 18.01% | 137.50K 23.32% | 199K 44.73% | 410.50K 106.28% | 392.50K 4.38% | 79K 79.87% | |
book value per share | 1.88 - | 0.52 72.46% | 0.73 41.64% | 0.10 86.38% | -0.00 101.70% | -0.17 9,974.78% | -0.18 3.73% | -0.18 2.73% | 0.00 101.72% | ||
capex per share | -0.00 - | -0.22 8,967.89% | -0.02 90.92% | -0.01 68.12% | |||||||
capex to depreciation | -0.17 - | -7.79 4,439.67% | -0.64 91.73% | -0.22 66.27% | |||||||
capex to operating cash flow | 0.00 - | 0.19 11,396.52% | 0.06 69.98% | 0.01 76.77% | |||||||
capex to revenue | -0.19 - | -2.84 1,420.32% | -0.02 99.12% | -0.02 32.58% | |||||||
cash per share | 2.73 - | 1.24 54.68% | 1.23 0.24% | 0.23 81.70% | 0.14 38.19% | 0.00 96.92% | 0.03 649.65% | 0.01 60.39% | 0.00 91.04% | ||
days of inventory on hand | 803.64 - | 488.81 39.18% | 153.57 68.58% | 250.08 62.85% | |||||||
days payables outstanding | 877.28 - | 348.92 60.23% | 514.12 47.34% | 62.32 87.88% | 8.55 86.27% | 57.87 - | |||||
days sales outstanding | 931.79 - | 69.01 92.59% | 5.10 92.61% | 12.43 143.66% | 8.74 29.70% | 181.61 1,978.54% | 26.65 85.33% | 64.11 140.54% | 36.90 42.44% | ||
debt to assets | 0.35 - | 0.60 69.43% | 0.46 23.86% | 0.65 42.78% | 0.59 10.31% | 1.96 235.44% | 2.34 19.31% | 3.61 54.20% | 0.21 94.11% | ||
debt to equity | 0.57 - | 1.92 240.01% | 0.98 49.01% | 4.53 361.42% | -99.78 2,304.24% | -1.17 98.83% | -1.27 8.37% | -1.06 15.91% | 1.03 196.61% | ||
dividend yield | |||||||||||
earnings yield | -0.17 - | -0.60 244.48% | -0.18 69.21% | -0.81 339.29% | -0.88 8.95% | -1.58 78.74% | -0.64 59.35% | -0.24 61.99% | -0.04 84.45% | ||
enterprise value | 77.03M - | 30.95M 59.82% | 32.26M 4.22% | 11.77M 63.50% | 6.90M 41.42% | 6.56M 4.84% | 11.28M 71.94% | 12.64M 12.05% | 28.49M 125.30% | ||
enterprise value over ebitda | -5.62 - | -2.54 54.86% | -8.07 218.02% | -1.80 77.74% | -1.32 26.45% | -1.81 37.28% | -15.56 758.26% | -19.97 28.33% | -23.46 17.48% | ||
ev to operating cash flow | -5.63 - | -2.80 50.24% | -8.75 212.11% | -2.12 75.80% | -1.53 27.74% | -1.68 9.82% | -18.26 987.26% | -17.58 3.69% | -38.39 118.32% | ||
ev to sales | 626.23 - | 41.21 93.42% | 3.76 90.88% | 2.64 29.79% | 2.33 11.83% | 16.01 588.39% | 4.25 73.47% | 3.54 16.61% | 18.22 414.61% | ||
free cash flow per share | -1.43 - | -1.35 6.03% | -0.36 73.18% | -0.47 31.42% | -0.28 40.29% | -0.18 34.83% | -0.02 87.49% | -0.02 3.82% | -0.01 41.28% | ||
free cash flow yield | -0.17 - | -0.60 248.71% | -0.14 75.86% | -0.62 328.63% | -0.70 13.32% | -1.61 129.05% | -0.10 93.75% | -0.11 5.35% | -0.03 75.34% | ||
graham net net | 1.65 - | 0.12 92.47% | 0.42 235.63% | -0.34 182.57% | -0.15 56.82% | -0.26 76.23% | -0.24 9.82% | -0.21 11.44% | -0.01 95.79% | ||
graham number | 7.84 - | 3.96 49.44% | 2.76 30.39% | 1.18 57.17% | 0.12 90.11% | 0.84 615.77% | 0.77 8.13% | 0.46 40.29% | 0.04 92.02% | ||
income quality | 0.98 - | 0.84 15.03% | 0.74 11.59% | 0.75 1.86% | 0.79 5.41% | 1.02 28.15% | 0.16 83.90% | 0.60 263.48% | 0.84 41.83% | ||
intangibles to total assets | 0 - | 0.11 Infinity% | 0.10 15.23% | 0.17 80.53% | 0.27 52.49% | 0.47 77.76% | 0.32 33.10% | 0.04 86.70% | 0.51 1,111.16% | 0 100% | |
interest coverage | -1.57K - | -10.07 99.36% | -3.46 65.64% | -7.34 112.33% | -8.77 19.40% | -17.56 100.26% | -1.61 90.80% | -1.68 4.32% | -6.07 260.36% | ||
interest debt per share | 1.06 - | 1.12 5.20% | 0.83 26.19% | 0.53 36.20% | 0.21 60.70% | 0.21 1.65% | 0.24 14.77% | 0.21 13.87% | 0.01 96.76% | ||
inventory turnover | 0.45 - | 0.75 64.41% | 2.38 218.30% | 1.46 38.59% | |||||||
invested capital | 0.57 - | 1.92 240.01% | 0.98 49.01% | 4.53 361.42% | -99.78 2,304.24% | -1.17 98.83% | -1.27 8.37% | -1.06 15.91% | 1.03 196.61% | ||
market cap | 79.77M - | 22.00M 72.42% | 26.99M 22.67% | 9.10M 66.29% | 6.42M 29.41% | 2.43M 62.17% | 6.15M 152.94% | 6.79M 10.44% | 28.40M 318.44% | ||
net current asset value | 16.75M - | 2.09M 87.53% | 5.07M 143.01% | -1.11M 121.97% | -2.06M 85.20% | -5.31M 157.05% | -6.13M 15.39% | -6.45M 5.27% | -310K 95.19% | ||
net debt to ebitda | 0.20 - | -0.73 466.79% | -1.32 79.60% | -0.41 69.02% | -0.09 77.74% | -1.14 1,157.92% | -7.09 520.55% | -9.25 30.54% | -0.07 99.24% | ||
net income per share | -1.46 - | -1.35 7.18% | -0.46 65.79% | -0.62 34.69% | -0.36 42.60% | -0.18 49.15% | -0.15 18.64% | -0.05 65.30% | -0.02 62.97% | ||
operating cash flow per share | -1.43 - | -1.13 21.12% | -0.34 69.75% | -0.47 37.19% | -0.28 39.49% | -0.18 34.83% | -0.02 87.49% | -0.02 3.82% | -0.01 41.28% | ||
payables turnover | 0.42 - | 1.05 151.43% | 0.71 32.13% | 5.86 725.00% | 42.67 628.46% | 6.31 - | |||||
receivables turnover | 0.39 - | 5.29 1,250.13% | 71.56 1,253.03% | 29.37 58.96% | 41.77 42.24% | 2.01 95.19% | 13.70 581.45% | 5.69 58.43% | 9.89 73.74% | ||
research and ddevelopement to revenue | 40.02 - | 6.10 84.76% | 0.30 95.02% | 0.90 197.10% | 1.25 39.03% | 4.29 241.97% | 0.57 86.80% | 0.50 11.93% | 0.98 95.45% | ||
return on tangible assets | -0.49 - | -0.92 89.58% | -0.33 64.63% | -1.09 234.83% | -1.68 54.20% | -3.39 101.36% | -2.25 33.40% | -1.00 55.78% | -2.56 156.46% | ||
revenue per share | 0.01 - | 0.08 496.45% | 0.80 935.70% | 0.38 52.72% | 0.19 50.41% | 0.02 89.60% | 0.10 412.86% | 0.11 11.08% | 0.03 75.09% | ||
roe | -0.78 - | -2.61 237.11% | -0.63 75.85% | -6.25 888.91% | 210.44 3,469.73% | 1.06 99.50% | 0.83 21.56% | 0.28 66.22% | -6.06 2,253.80% | ||
roic | -0.50 - | -0.88 76.06% | -0.30 66.30% | -1.08 261.50% | -1.91 77.59% | -7.24 278.09% | -0.60 91.67% | -2.75 356.65% | -3.63 31.74% | ||
sales general and administrative to revenue | 1.46 - | 0.71 - | 0.71 0.99% | 0.80 12.37% | |||||||
shareholders equity per share | 1.88 - | 0.52 72.46% | 0.73 41.64% | 0.10 86.38% | -0.00 101.70% | -0.17 9,974.78% | -0.18 3.73% | -0.18 2.73% | 0.00 101.72% | ||
stock based compensation to revenue | 9.88 - | 1.19 88.00% | 0.07 94.05% | 0.13 86.65% | 0.16 18.77% | 0.53 239.88% | 0.04 92.36% | 0.01 75.19% | 0.04 267.99% | ||
tangible asset value | 17.92M - | 3.21M 82.11% | 6.26M 95.26% | -248K 103.96% | -1.25M 404.44% | -4.63M 270.42% | -5.55M 19.79% | -5.96M 7.44% | -260K 95.64% | ||
tangible book value per share | 1.88 - | 0.33 82.52% | 0.58 76.87% | -0.02 103.60% | -0.08 276.51% | -0.22 178.58% | -0.21 5.20% | -0.18 11.18% | 0.00 101.70% | ||
working capital | 26.35M - | 10.24M 61.14% | 10.89M 6.37% | 2.42M 77.75% | -2.06M 185.22% | -974K 52.83% | 104K 110.68% | -6.34M 6,199.04% | -143K 97.75% |
All numbers in (except ratios and percentages)